You are here

  • Home
  • Archive
  • Volume 9, Issue 6
  • Δ133p53α enhances metabolic and cellular fitness of TCR-engineered T cells and promotes superior antitumor immunity

Article metrics

Article menu
XML
Immune cell therapies and immune cell engineering
Original research
Δ133p53α enhances metabolic and cellular fitness of TCR-engineered T cells and promotes superior antitumor immunity

 

Online download statistics by month:

Online download statistics by month: June 2021 to September 2025

AbstractFullPdf
Jun 2021494494189
Jul 202122322271
Aug 202114114133
Sep 202114915172
Oct 2021979771
Nov 2021949442
Dec 2021707026
Jan 2022808130
Feb 2022505220
Mar 2022626428
Apr 2022647026
May 2022666938
Jun 2022646526
Jul 2022575720
Aug 2022474713
Sep 2022606034
Oct 2022585922
Nov 2022464622
Dec 2022424212
Jan 2023444418
Feb 2023727420
Mar 2023353541
Apr 2023424530
May 2023262611
Jun 2023383812
Jul 2023595923
Aug 202357579
Sep 2023464815
Oct 2023494919
Nov 2023707012
Dec 202313913929
Jan 20244445104
Feb 2024434525
Mar 2024626353
Apr 2024434323
May 2024535425
Jun 2024676620
Jul 2024757620
Aug 2024515218
Sep 20244647990
Oct 2024515186
Nov 2024545518
Dec 2024576019
Jan 2025616117
Feb 2025494927
Mar 2025444429
Apr 2025474828
May 2025555524
Jun 2025646429
Jul 2025110
Sep 2025110
Total360936452589